Status:
UNKNOWN
Magnesium Sulfate in Thrombotic Thrombocytopenic Purpura in Intensive Care
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Thrombotic Thrombocytopenic Purpura
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Thrombotic Thrombocytopenic Purpura (TTP) is a potentially life-threatening thrombotic microangiopathy caused by a severe deficiency of ADAMTS13 (a disintegrin and metalloproteinase with a thrombospon...
Eligibility Criteria
Inclusion
- Age \> or = 18 years
- Health insurance
- Signed inform consent by patient or relatives
Exclusion
- Pregnancy
- No health insurance
Key Trial Info
Start Date :
May 27 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT03237819
Start Date
May 27 2018
End Date
December 1 2021
Last Update
October 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Saint Louis hospital
Paris, France, 75010